Institutional Ownership
Halozyme Therapeutics Inc
CUSIP 40637H109COMHALOQ1 2026
Institutional Holders
625
13F filers
Shares Held
108.69M
Aggregate institutional
Institutional Value
$6.71B
Q1 2026
Net New Holders
+21
84 new · 63 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions84
Increased235
Decreased212
Sold out63
Institutional Holders
625 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | 13.27M | $857.32M | +111.2K | Added |
| 2 | State Street Corp | 4.94M | $319.13M | −183.8K | Reduced |
| 3 | Invesco Ltd. | 4.01M | $259.33M | +364.4K | Added |
| 4 | Bank Of America Corp /De/ | 2.91M | $188.27M | +179.3K | Added |
| 5 | Boston Partners | 2.68M | $173.43M | +2.20M | Added |
| 6 | Morgan Stanley | 2.56M | $165.60M | −96.0K | Reduced |
| 7 | William Blair Investment Management, LLC | 2.53M | $163.25M | +683.0K | Added |
| 8 | Geode Capital Management, LLC | 2.51M | $161.98M | +72.6K | Added |
| 9 | Snyder Capital Management L P | 2.32M | $150.14M | −76.1K | Reduced |
| 10 | Dimensional Fund Advisors LP | 2.08M | $134.40M | −24.3K | Reduced |
615 more institutional holders on Premium
See every fund holding Halozyme Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders